Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

CytoDyn reports phase III data on leronlimab in critically ill COVID-19 patients

March 8, 2021

Neumifil is efficacious in hamster model of COVID-19 infection

March 8, 2021

FDA approves phase III study of proxalutamide in COVID-19

March 8, 2021

Study sponsors discontinue testing of razuprotafib in I-SPY COVID trial

March 8, 2021

Headless hemagglutinin induces broad influenza antibodies

March 8, 2021

TurnSole initiates phase I/II study of TS-020 in hospitalized COVID-19 patients

March 5, 2021

NIAID closes ACTIV-3 substudies of BRII-196, BRII-198 and VIR-7831

March 5, 2021

Apellis ends development of APL-9 for severe COVID-19

March 5, 2021

COVID-eVax vaccine enters phase I/II study

March 4, 2021

Arbutus Biopharma identifies HBsAg secretion inhibitors

March 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...